["{\n\"step_by_step_thinking\": \"The patient has Burkholderia cepacia pneumonia. We can start by looking at the documents for information on Burkholderia cepacia treatment. In [Treatment of pneumonia in childhood], there is no specific mention of treating Burkholderia cepacia pneumonia, but it does provide general guidelines for treating pneumonias. In [Nosocomial respiratory infection caused by Pseudomonas cepacia], we can see that Pseudomonas cepacia is a gram negative rod and was detected in patients with severe underlying diseases. This might suggest that Burkholderia cepacia, which is similar to Pseudomonas cepacia, may require different treatment options.\n\nIn [Antimicrobial susceptibility patterns of clinical isolates of Pseudomonas cepacia], we can see that most strains were resistant to many antibiotics, but minocycline and miloxacin inhibited more than 95% of the strains. This might suggest that these antibiotics could be effective against Burkholderia cepacia.\n\nIn [Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia], we can see that some antibiotics demonstrated post-antibiotic effects (PAE) against Pseudomonas cepacia. This might suggest that these antibiotics could be effective against Burkholderia cepacia as well.\n\nBased on this information, the most effective treatment options for Burkholderia cepacia pneumonia would likely involve antibiotics with PAE and those that have been shown to inhibit Burkholderia cepacia in vitro. This could include minocycline, miloxacin, or other antibiotics that have demonstrated PAE against Pseudomonas cepacia.\n\nLooking at the available choices, we can see that A: Aminoglycoside and colistin is not a suitable option as it does not account for the post-antibiotic effect of the antibiotic. B: Carbapenems with 3rd generation cephalosporins could be a suitable option as carbapenems have been shown to inhibit Pseudomonas cepacia in vitro and may have a PAE against Burkholderia cepacia. C: Tigecycline and cefipime is not a suitable option as tigecycline has not been shown to inhibit Pseudomonas cepacia in vitro. D: Cotrimoxazole with 3rd generation cephalosporins could be a suitable option as cotrimoxazole has been shown to inhibit Pseudomonas cepacia in vitro and may have a PAE against Burkholderia cepacia.\n\nBased on this information, the most effective treatment options for Burkholderia cepacia pneumonia would likely involve antibiotics with PAE and those that have been shown to inhibit Burkholderia cepacia in vitro. This could include minocycline, miloxacin, or other antibiotics that have demonstrated PAE against Pseudomonas cepacia.\n\nGiven these choices, the most suitable option would be B: Carbapenems with 3rd generation cephalosporins.\",\n\"answer_choice\": \"B\""]